Valneva SE (VALN) Amortization - Intangibles (2022 - 2026)
Valneva SE (VALN) posted Amortization - Intangibles of $1.4 million for Q1 2026, up 0.58% sequentially from $1.4 million in Q4 2025, and up 11.3% YoY from $1.3 million in Q1 2025.
Valneva SE (VALN) Amortization - Intangibles (2022 - 2026) Analysis & Trends
Valneva SE has reported Amortization - Intangibles for 5 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Amortization - Intangibles rose 11.3% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 7.92% YoY) and the FY2025 annual result came in at $5.6 million, up 5.35% from the prior year.
- Amortization - Intangibles grew to $1.4 million in Q1 2026 per VALN's latest filing, from $1.4 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $5.3 billion in Q3 2022 and troughed at -$5.4 billion in Q4 2022.
- A 5-year average of -$2.7 million and a median of $1.4 million in 2025 frame the typical range for Amortization - Intangibles.
- The widest YoY moves for Amortization - Intangibles: up 100.02% in 2023, down 99.97% in 2023.
- Over 5 years, Amortization - Intangibles stood at -$5.4 billion in 2022, then jumped by 100.02% to $1.2 million in 2023, then grew by 8.35% to $1.3 million in 2024, then gained by 8.93% to $1.4 million in 2025, then grew by 0.58% to $1.4 million in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $1.4 million, $1.4 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | -5.36 Bn |
| Sep 30, 2022 | 5.30 Bn |